BIOPOLYMER MARKER INDICATIVE OF DISEASE STATE HAVING A MOLECULAR WEIGHT OF 1949 DALTONS

Details for Australian Patent Application No. 2002252911 (hide)

Owner SYN.X PHARMA, INC.

Inventors YANTHA, Jason; VREES, Tammy; JACKOWSKI, George; THATCHER, Brad; MARSHALL, John

Pub. Number AU-A-2002252911

PCT Pub. Number WO2002/088746

Priority 09/845,727 30.04.01 US

Filing date 29 April 2002

Wipo publication date 11 November 2002

International Classifications

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

C07K 007/08 Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

17 April 2003 Application Open to Public Inspection

  Published as AU-A-2002252911

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002252912-BIOPOLYMER MARKER INDICATIVE OF DISEASE STATE HAVING A MOLECULAR WEIGHT OF 2021 DALTONS

2002252910-BIOPOLYMER MARKER INDICATIVE OF DISEASE STATE HAVING A MOLECULAR WEIGHT OF 2267 DALTONS